Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Market Analysis & Valuation

UpdatedMar 13, 2026
DataAggregated Company Financials
Companies206
  • 7D-3.0%
  • 3M0.7%
  • 1Y1.0%
  • YTD-2.3%

Over the last 7 days, the market has dropped 3.0%, driven by a decline of 5.8% in the Healthcare sector. Although the market performance has been flat over the past year. Looking forward, earnings are forecast to grow by 11% annually.

Market Valuation and Performance

Has the Swiss Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 13 Mar 2026CHF 1.9tCHF 778.4bCHF 109.2b20x17.6x2.5x
Sun, 08 Feb 2026CHF 2.0tCHF 789.8bCHF 117.7b20.9x17.1x2.6x
Tue, 06 Jan 2026CHF 2.0tCHF 796.7bCHF 114.8b20.6x17.4x2.5x
Thu, 04 Dec 2025CHF 1.9tCHF 805.7bCHF 115.0b19.6x16.8x2.4x
Sat, 01 Nov 2025CHF 1.9tCHF 778.5bCHF 92.1b19.2x20.3x2.4x
Mon, 29 Sep 2025CHF 1.8tCHF 774.4bCHF 90.3b19x20.1x2.3x
Wed, 27 Aug 2025CHF 1.9tCHF 776.2bCHF 90.0b20.3x20.6x2.4x
Fri, 25 Jul 2025CHF 1.8tCHF 787.9bCHF 107.6b20.4x17.2x2.3x
Sun, 22 Jun 2025CHF 1.8tCHF 782.1bCHF 106.5b20x16.8x2.3x
Tue, 20 May 2025CHF 1.8tCHF 789.0bCHF 106.8b20.2x17.2x2.3x
Thu, 17 Apr 2025CHF 1.7tCHF 831.2bCHF 156.5b18.5x10.9x2.1x
Sat, 15 Mar 2025CHF 1.9tCHF 849.9bCHF 158.9b19.8x11.9x2.2x
Mon, 10 Feb 2025CHF 1.9tCHF 822.9bCHF 116.7b21.9x16x2.3x
Wed, 08 Jan 2025CHF 1.8tCHF 817.7bCHF 117.8b20.9x15x2.2x
Fri, 06 Dec 2024CHF 1.8tCHF 808.7bCHF 116.9b21x15.1x2.2x
Sun, 03 Nov 2024CHF 1.8tCHF 810.6bCHF 117.6b20.5x15.2x2.2x
Tue, 01 Oct 2024CHF 1.8tCHF 801.1bCHF 113.9b21.7x16x2.3x
Thu, 29 Aug 2024CHF 1.8tCHF 798.8bCHF 113.6b21.9x16.2x2.3x
Sat, 27 Jul 2024CHF 1.8tCHF 795.6bCHF 124.8b21.5x14.7x2.3x
Mon, 24 Jun 2024CHF 1.8tCHF 799.8bCHF 125.5b21.7x14.4x2.3x
Wed, 22 May 2024CHF 1.8tCHF 803.3bCHF 126.5b22.2x14.3x2.3x
Fri, 19 Apr 2024CHF 1.7tCHF 767.9bCHF 96.9b20.8x17.7x2.2x
Sun, 17 Mar 2024CHF 1.8tCHF 766.4bCHF 97.8b21.1x18x2.3x
Tue, 13 Feb 2024CHF 1.7tCHF 766.8bCHF 109.2b19.5x15.5x2.2x
Thu, 11 Jan 2024CHF 1.7tCHF 761.4bCHF 109.5b18.4x15.4x2.2x
Sat, 09 Dec 2023CHF 1.7tCHF 769.9bCHF 111.1b18.5x15x2.2x
Mon, 06 Nov 2023CHF 1.6tCHF 771.2bCHF 112.8b17.8x14.1x2.1x
Wed, 04 Oct 2023CHF 1.6tCHF 751.0bCHF 100.0b18.3x16.3x2.2x
Fri, 01 Sep 2023CHF 1.7tCHF 747.4bCHF 74.8b19.1x22.5x2.2x
Sun, 30 Jul 2023CHF 1.7tCHF 740.8bCHF 77.3b18.3x22.2x2.3x
Tue, 27 Jun 2023CHF 1.7tCHF 757.4bCHF 76.9b18.8x22.1x2.2x
Thu, 25 May 2023CHF 1.7tCHF 787.7bCHF 82.7b18.8x21x2.2x
Sat, 22 Apr 2023CHF 1.8tCHF 774.3bCHF 69.1b19.4x25.8x2.3x
Mon, 20 Mar 2023CHF 1.7tCHF 783.5bCHF 70.0b19.2x23.8x2.1x
Price to Earnings Ratio

23.8x


Total Market Cap: CHF 1.7tTotal Earnings: CHF 70.0bTotal Revenue: CHF 783.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Market Price to Earnings3Y Average 17.2x202420252026
Current Market PE
  • Investors are relatively neutral on the Swiss market at the moment, indicating that they expect earnings will grow in line with historical growth rates.
  • The market is trading close to its 3-year average PE ratio of 17.2x.
Past Earnings Growth
  • The earnings for Swiss listed companies have grown 16% per year over the last three years, while revenues have remained steady.
  • This means that companies overall are more efficiently conducting business since profits are increasing while sales have been flat.

Sector Trends

Which sectors have driven the changes within the Swiss Market?

CH Market-3.00%
Utilities4.06%
Tech1.44%
Industrials-0.43%
Consumer Staples-0.81%
Telecom-1.08%
Consumer Discretionary-1.12%
Financials-1.59%
Real Estate-2.67%
Materials-5.10%
Healthcare-5.85%
Sector PE
  • Investors favour the Tech sector the most for future growth, which is trading above its 3-year average PE ratio of 29.9x.
    • The market's confidence is likely because analysts are expecting annual earnings growth of 19.6% which is higher than its past year's earnings decline of 5.7% per year.
  • The Financials sector is the least preferred by investors for future growth, which is trading close to its 3-year average of 7.8x.
Forecasted Growth
  • Analysts are most optimistic on the Tech sector, expecting annual earnings growth of 20% over the next 5 years.
  • This is better than its past earnings decline of 5.7% per year.
  • In contrast, the Real Estate sector is expected to see its earnings decline by 9.8% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
ZURN Zurich Insurance GroupCHF 534.40-0.1%
CHF 3.7b		-11.2%PE14.9xFinancials
ABBN ABBCHF 67.721.7%
+CHF 2.1b		40.6%PE34.3xIndustrials
LOGN Logitech InternationalCHF 73.444.5%
+CHF 463.2m		-7.4%PE19.2xTech
ACLN Accelleron IndustriesCHF 74.156.0%
+CHF 394.4m		76.4%PE45.4xIndustrials
BKW BKWCHF 152.405.0%
+CHF 385.2m		2.5%PE22.5xUtilities
See more

Market Insights

Header cover image
Why international stocks are starting to outpace the U.S.
Stella Ong avatar
Stella Ong
From Europe to Asia, global markets surged in 2025 while U.S. earnings growth became more concentrated. Early signs suggest this might continue.
Continue reading
What the next 25 years will look like 🔮

Latest News

UBSG
CHF 29.51
UBS Group
7D
-3.5%
1Y
5.2%
TEMN
CHF 75.60
Temenos
7D
4.6%
1Y
9.2%
LISN
CHF 115,400.00
Chocoladefabriken Lindt & Sprüngli
7D
-5.6%
1Y
1.8%

LISN: Premium Brand And Margin Outlook Will Support Future Re Rating

We trim our fair value estimate for Chocoladefabriken Lindt & Sprüngli to CHF 137,000 from CHF 144,624, reflecting a series of lower analyst price targets in the CHF 100,000 to CHF 108,500 range as they reassess the stock's premium valuation against recent cocoa price moves and updated margin expectations. Analyst Commentary Recent Street research has tilted cautious, with several high profile houses revisiting their assumptions on Chocoladefabriken Lindt & Sprüngli as cocoa markets and margin expectations are reassessed.
ROG
CHF 318.20
Roche Holding
7D
-9.5%
1Y
5.0%
AMRZ
CHF 44.64
Amrize
7D
-6.8%
1Y
n/a
NOVN
CHF 120.84
Novartis
7D
-3.2%
1Y
24.7%

NOVN: Dividend Progress And US Manufacturing Expansion Will Shape Balanced Future Returns

Analysts have nudged their fair value estimate for Novartis up from about CHF116.24 to around CHF117.49. This mainly reflects slightly higher expected profit margins and a modestly higher future P/E assumption, while revenue growth expectations are a touch lower.
ACLN
CHF 74.15
Accelleron Industries
7D
6.0%
1Y
76.4%

ACLN: Higher Margin Expectations Will Support A More Optimistic Future P/E

Analysts have raised their price target on Accelleron Industries to CHF 70 from CHF 62, reflecting updated assumptions around fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Price target moves to CHF 70 signal that bullish analysts see the updated valuation framework as more aligned with their current assumptions on fair value, discount rate, revenue growth, profit margin and future P/E.
SFSN
CHF 120.20
SFS Group
7D
4.5%
1Y
0.5%
BKW
CHF 152.40
BKW
7D
5.0%
1Y
2.5%

BKW: Higher Future P/E And Reset EBIT Guidance Will Drive Re Rating

Narrative Update on BKW Analysts have trimmed their price target on BKW to about CHF 165 from around CHF 170. They cited more cautious assumptions on revenue growth and profit margins, partly offset by a higher expected future P/E multiple and recent neutral to cautious coverage from the Street.
HOLN
CHF 62.06
Holcim
7D
-7.6%
1Y
-36.5%

HOLN: Cement Pricing Resilience In Europe Will Drive Rebound Potential

Our revised fair value estimate for Holcim has risen from CHF 70 to CHF 93. This reflects analysts' updated price targets in the CHF 72 to CHF 80 range and their view that recent share weakness has been overdone, while near term cement pricing in Europe is expected to hold.
ZURN
CHF 534.40
Zurich Insurance Group
7D
-0.1%
1Y
-11.2%

ZURN: Future Returns Will Rely On Dividend Strength And Moderating P/E Assumptions

Zurich Insurance Group's analyst price target has been adjusted from about CHF 575 to CHF 568, even as some analysts have lifted their own targets (for example, a move to CHF 656), reflecting updated views on revenue, margins and future P/E assumptions. Analyst Commentary Bullish analysts lifting their price targets toward CHF 656 are signaling confidence that Zurich Insurance Group's earnings profile can support a higher valuation multiple over time, even with a central price target now closer to CHF 568.
LOGN
CHF 73.44
Logitech International
7D
4.5%
1Y
-7.4%

LOGN: Future Returns Will Be Led By AI Meeting Solutions

Analysts have trimmed their price target on Logitech International to CHF 89.84 from CHF 93.34, reflecting slightly lower revenue growth expectations and a modestly higher discount rate that are only partly offset by a small uplift in projected profit margins. What's in the News Logitech G introduced the G325 LIGHTSPEED Wireless Gaming Headset, a US$79.99 wireless model positioned to offer LIGHTSPEED performance, 24 bit audio, and all day comfort in a minimalist design for PC, console, and mobile users (Product related announcement).
GALD
CHF 146.90
Galderma Group
7D
-5.2%
1Y
61.8%
ABBN
CHF 67.72
ABB
7D
1.7%
1Y
40.6%
GRKP
CHF 2,170.00
Graubündner Kantonalbank
7D
3.8%
1Y
25.4%
LONN
CHF 484.50
Lonza Group
7D
-5.8%
1Y
-10.4%